Christopher Allen

San Francisco and Boston sit on opposite coasts and each has a rich history and character that make them distinct. However, they share some similarities: both cities are centers of top biotechnology hubs in the US.

The prescription drug-abuse problem in the US has grown to epidemic proportions in recent years. According to MedlinePlus, a service of the US National Library of Medicine.

Earlier this year, the concept of solar-powered aviation was further propelled from its proverbial runway, testing many limits that had not been previously realized in the realm of energy-efficient transportation.

Biopharmaceutical manufacturing has certainly come a long way in terms of innovation, but now it has many more miles to go, literally-on a truck.

Federal Judge Jose L. Linares of the District Court of New Jersey has ruled to move forward to hear an antitrust suit filed by a group of doctors against Sanofi in December 2011.

Athletics and drugs do not share the spotlight often, but when the two combine, it usually turns heads.

Efficient energy consumption has taken to the friendly skies with a little help from the sun-and pharma.

In contentious three days of hearing on the Affordable Care Act, the Supreme Court now seems far more likely to overturn the landmark legislation.

Amid one of the most divisive eras in our nation’s political history, one thing we can all pretty much agree on is the fact that our stalled economic engine needs a jumpstart.

New Jersey is known to many as a pharmaceutical mecca on the international stage with several leading pharmaceutical majors headquartered and/or with operations in the state. So to say that lawmakers need to create an economic climate conducive to foster growth is an understatement.